PRIME: PReservIng Memory in Epilepsy

Abroad (travel likely)Recruiting

Conditions

Mesial Temporal Lobe Epilepsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Gregory Worrell, MD, PhD) · worrell.gregory@mayo.edu
The University of Texas Science Center at Houston, Houston, Texas, United States
Contact: Study coordinator (Jessica Johnson, MSN, NP-C) · Jessica.A.Johnson@uth.tmc.edu · 713-500-5443
Contact: Study coordinator (Eliana Klier, PhD) · Eliana.Klier@uth.tmc.edu · 713-500-5442

Study leads

Nitin Tandon, MD
Principal Investigator
The University of Texas Health Science Center, Houston

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Mesial Temporal Lobe Epilepsy

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Phoenix, United States

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

Mesial Temporal Lobe Epilepsy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Phoenix, United States

Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)

Epilepsy · MTLE

Abroad (travel likely)RecruitingEARLY_PHASE1

Hangzhou, China

Pharmacological Modulation of Brain Oscillations in Memory Processing

Epilepsy · Seizures · Cognitive Impairment, Mild

Abroad (travel likely)RecruitingEARLY_PHASE1

Dallas, United States